Business
Roche Bets $2.5B on an Obesity Drug That Aims to Spare Muscle
Licensing HM17321 from Korea’s Hanmi, Roche is chasing the next frontier in weight loss: shedding fat while preserving the muscle that today’s GLP-1 drugs also strip away.